Vanguard Group Inc Atea Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,851,218 shares of AVIR stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,851,218

Previous 4,724,405 2.68%

Holding current value

$15 Million

Previous $15.6 Million 3.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $401,997 - $509,788	126,813 Added 2.68%	4,851,218 $16.3 Million
Q2 2024 Aug 13, 2024	BUY	$3.31 - $4.04 $6,232 - $7,607	1,883 Added 0.04%	4,724,405 $15.6 Million
Q1 2024 May 10, 2024	BUY	$3.09 - $4.56 $379,489 - $560,022	122,812 Added 2.67%	4,722,522 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $73,556 - $88,004	26,270 Added 0.57%	4,599,710 $14 Million
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $167,523 - $211,637	55,841 Added 1.24%	4,573,440 $13.7 Million
Q2 2023 Aug 14, 2023	SELL	$3.21 - $5.06 $223,358 - $352,084	-69,582 Reduced 1.52%	4,517,599 $16.9 Million
Q1 2023 May 15, 2023	SELL	$3.0 - $4.97 $4.51 Million - $7.47 Million	-1,502,341 Reduced 24.67%	4,587,181 $15.4 Million
Q4 2022 Feb 10, 2023	SELL	$4.35 - $6.17 $6.5 Million - $9.22 Million	-1,494,734 Reduced 19.71%	6,089,522 $29.3 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $2.22 Million - $3.55 Million	403,971 Added 5.63%	7,584,256 $43.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.33 - $8.18 $2.4 Million - $3.69 Million	451,082 Added 6.7%	7,180,285 $51 Million
Q1 2022 May 13, 2022	BUY	$5.5 - $9.19 $5.21 Million - $8.71 Million	947,321 Added 16.38%	6,729,203 $48.6 Million
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $4.62 Million - $26.8 Million	601,927 Added 11.62%	5,781,882 $51.7 Million
Q3 2021 Nov 12, 2021	BUY	$21.33 - $35.06 $13.7 Million - $22.6 Million	643,792 Added 14.19%	5,179,955 $182 Million
Q2 2021 Aug 13, 2021	BUY	$19.22 - $59.08 $87.2 Million - $268 Million	4,536,163 New	4,536,163 $97.4 Million

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $258M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Atea Pharmaceuticals, Inc. Transaction History